Fighting Cancer: A Basic Guide To Checkpoint Inhibitors
People with cancer may encounter checkpoint inhibitors as a treatment option but may not know where to start. This article can help you learn more.
Source: forbes.com
Microsatellite Instability High News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Microsatellite Instability High. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Microsatellite Instability High Today - Breaking & Trending Today
Immunotherapy Combo Wins Big on PFS in First-Line Mets CRC
First-line nivolumab plus ipilimumab led to significantly better 2-year PFS in metastatic CRC than chemotherapy as well as pembrolizumab monotherapy.
Source: medscape.com
Botensilimab/Balstilimab Breakthrough Data Presented at ASCO-GI Shows Unprecedented Tumor Shrinkage and Robust Biomarker Response in Prevalent Colorectal Cancer Population
22.01.2024 - Agenus Inc. (Nasdaq: AGEN), a leader in developing immunological cancer treatments, today announced results from the NEST-1 study, an investigator-sponsored trial (IST) evaluating the combination of botensilimab and balstilimab (BOT/BAL) in the ... Seite 1
Source: wallstreet-online.de
Retifanlimab Continues to Show Activity in Recurrent MSI-H or dMMR Endometrial Cancer
Retifanlimab-dlwr continued to elicit responses with acceptable tolerability in patients with recurrent microsatellite instability–high or mismatch–repair deficient endometrial cancer, according to final findings from cohort H of the phase 1 POD1UM-101 trial.
Source: onclive.com
Molecular Templates Announces First Patient Dosed in Phase
AUSTIN, Texas, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage...
Source: globenewswire.com